These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Applications of laser capture microdissection in the study of neurodegenerative disease. Standaert DG Arch Neurol; 2005 Feb; 62(2):203-5. PubMed ID: 15710848 [No Abstract] [Full Text] [Related]
6. Drosophila in the study of neurodegenerative disease. Marsh JL; Thompson LM Neuron; 2006 Oct; 52(1):169-78. PubMed ID: 17015234 [TBL] [Abstract][Full Text] [Related]
7. Drosophila: a "model" model system to study neurodegeneration. Celotto AM; Palladino MJ Mol Interv; 2005 Oct; 5(5):292-303. PubMed ID: 16249525 [TBL] [Abstract][Full Text] [Related]
8. Functional DNA array' in the fly: implication for neuronal degeneration. Kanuka H; Miura M Cell Death Differ; 2002 Mar; 9(3):231-3. PubMed ID: 11859404 [No Abstract] [Full Text] [Related]
10. Modeling age-related diseases in Drosophila: can this fly? Michno K; van de Hoef D; Wu H; Boulianne GL Curr Top Dev Biol; 2005; 71():199-223. PubMed ID: 16344106 [TBL] [Abstract][Full Text] [Related]
11. Unfolding the role of protein misfolding in neurodegenerative diseases. Soto C Nat Rev Neurosci; 2003 Jan; 4(1):49-60. PubMed ID: 12511861 [No Abstract] [Full Text] [Related]
12. Drosophila models of neurodegenerative diseases. Lu B; Vogel H Annu Rev Pathol; 2009; 4():315-42. PubMed ID: 18842101 [TBL] [Abstract][Full Text] [Related]
13. Dynamic regulation of molecular chaperone gene expression in polyglutamine disease. Huen NY; Chan HY Biochem Biophys Res Commun; 2005 Sep; 334(4):1074-84. PubMed ID: 16039613 [TBL] [Abstract][Full Text] [Related]
14. Region-specific analysis of mitochondrial DNA deletions in neurodegenerative disorders in humans. Mawrin C; Kirches E; Krause G; Schneider-Stock R; Bogerts B; Vorwerk CK; Dietzmann K Neurosci Lett; 2004 Mar; 357(2):111-4. PubMed ID: 15036587 [TBL] [Abstract][Full Text] [Related]
15. Role of non-coding RNAs in neurodegeneration and stress response in Drosophila. Savvateeva-Popova E; Medvedeva A; Popov A; Evgen'ev M Biotechnol J; 2008 Aug; 3(8):1010-21. PubMed ID: 18702036 [TBL] [Abstract][Full Text] [Related]
16. Using Caenorhabditis elegans models of neurodegenerative disease to identify neuroprotective strategies. Kraemer B; Schellenberg GD Int Rev Neurobiol; 2007; 77():219-46. PubMed ID: 17178476 [No Abstract] [Full Text] [Related]
17. Interfering with programmed cell death in neurodegenerative diseases: insights from experimental animal models. Vila M Drug Discov Today; 2004 Jun; 9(12):513-4. PubMed ID: 15183156 [No Abstract] [Full Text] [Related]
18. Brain copper elevation and neurological changes in north ronaldsay sheep: a model for neurodegenerative disease? Haywood S; Paris J; Ryvar R; Botteron C J Comp Pathol; 2008 Nov; 139(4):252-5. PubMed ID: 18786681 [TBL] [Abstract][Full Text] [Related]
19. The pathogenic agent in Drosophila models of 'polyglutamine' diseases. McLeod CJ; O'Keefe LV; Richards RI Hum Mol Genet; 2005 Apr; 14(8):1041-8. PubMed ID: 15757976 [TBL] [Abstract][Full Text] [Related]
20. Drosophila is an inclusive model for human diseases, growth and development. Gilbert LI Mol Cell Endocrinol; 2008 Oct; 293(1-2):25-31. PubMed ID: 18374475 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]